Latest Breaking News On - Office of orphan products development - Page 9 : comparemela.com

FDA grants priority review to cervical cancer, renal cell carcinoma therapies

FDA grants priority review to cervical cancer, renal cell carcinoma therapies
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesBaudax bioMindy valcarcelIdeaya biosciencesBymark leiserRegeneron pharmaceuticalsOffice of orphan products developmentKymera therapeuticsMythic therapeuticsOrphan products development

Form 10-K InMed Pharmaceuticals For: Jun 30

Form 10-K InMed Pharmaceuticals For: Jun 30
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealandUnited kingdomNew yorkBritish columbiaProvince of british columbiaSouth san franciscoGreat britainNicole lemerondErica adamsVikramaditya yadavAmryt pharma filsuvezBryan baldasareMauro maccarroneUjendra kumarAducanumab aduhelm

Bolt Biotherapeutics (BOLT) Granted Orphan Drug Designation for BDC-1001

Bolt Biotherapeutics (BOLT) Granted Orphan Drug Designation for BDC-1001
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEditha perezOffice of orphan products developmentDrug administrationOrphan drug designationChief medical officerOrphan products development

Baudax Bio Announces Orphan Drug Designation Granted by U S FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors

Baudax Bio Announces Orphan Drug Designation Granted by U S FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMike moyerGerri henwoodBaudax bioBaudax bio incOffice of orphan products developmentCompany or baudax bioDrug administrationBio announces orphan drug designation grantedNeuromuscular blocking agentsChief executive officerInvestigational new drugClinical trialOrphan products developmentOrphan drug designationUmbilical cord blood

Baudax Bio Shares Double After Orphan Drug Designation for TI-168

By Chris Wack Baudax Bio shares doubled to 67 cents after the company said that U.S. Food and Drug Administration has granted orphan drug designation to its.

Chris wackBaudax bioDrug administrationOffice of orphan products developmentInvestigational new drugOrphan products developmentArticle normalHealthcare life sciencesPolitical general newsGenetic disordersMedical conditionsGeneral newsLife sciences